Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | FBIO | NKGN | ||
| Company | Catabasis Pharma | Fortress Biotech Inc | Nkgen Biotech Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.21 | 1.8500 | 1.3300 | ||
| High | 9.21 | 1.8600 | 1.5500 | ||
| Low | 8.46 | 1.6700 | 1.3200 | ||
| Last | 8.54 | 1.7500 | 1.4300 | ||
| Change | -0.64 | -0.0500 | +0.1100 | ||
| % Change | -6.97% | -2.78% | +8.33% | ||
| Volume | 98,800 | 177,700 | 209,500 | ||
| 20-Day Average Volume | 395,311 | 191,220 | 2,509,490 | ||
| Previous Close | 9.18 | 1.8000 | 1.3200 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 1.7850 | 1.3868 | ||
| 20-Day Raw Stochastic | 56.46% | 28.13% | 47.25% | ||
| 20-Day Relative Strength | 43.24% | 45.18% | 47.78% | ||
| Weighted Alpha | -50.43 | -77.83 | -89.11 | ||
| Today's Opinion | 88% Sell | 100% Sell | 72% Sell | ||
| Previous Opinion | 72% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 96% Sell | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | +1.74% since 04/26/24 | -11.18% since 04/26/24 | ||
| Low | 8.46 on 09/08/21 | 1.6600 on 04/30/24 | 1.2800 on 05/02/24 | ||
| High | 10.26 on 09/02/21 | 1.8600 on 05/03/24 | 1.9000 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | -8.85% since 04/03/24 | -7.74% since 04/03/24 | ||
| Low | 6.31 on 08/20/21 | 1.6306 on 04/05/24 | 0.8210 on 04/18/24 | ||
| High | 10.26 on 09/02/21 | 1.9800 on 04/09/24 | 2.1100 on 04/25/24 | ||
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | -5.41% since 02/02/24 | -12.27% since 02/02/24 | ||
| Low | 6.31 on 08/20/21 | 1.6300 on 03/14/24 | 0.7802 on 03/04/24 | ||
| High | 15.72 on 06/16/21 | 2.6150 on 03/04/24 | 4.0600 on 03/06/24 | ||
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | -21.88% since 11/03/23 | -53.11% since 11/03/23 | ||
| Low | 6.31 on 08/20/21 | 1.2400 on 11/10/23 | 0.7802 on 03/04/24 | ||
| High | 22.01 on 03/18/21 | 4.4300 on 12/28/23 | 4.0600 on 03/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 33,661 | 32,168 | ||
| Shares Outstanding, K | 3,904 | 19,235 | 22,495 | ||
| Annual Sales | 0 | 84,510,000 | 0 | ||
| Annual Net Income | -37,300,000 | -60,640,000 | -82,940,000 | ||
| Last Quarter Sales | 0 | 19,950,000 | 0 | ||
| Last Quarter Net Income | -7,470,000 | -9,280,000 | -48,310,000 | ||
| 60-Month Beta | 1.66 | 1.56 | 0.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.53 on 03/28/24 | -1.68 on 04/16/24 | ||
| Latest Earnings Date | 08/09/21 | 05/20/24 | 04/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||